CTRI/2021/07/035082已完成4 期
An open label, prospective, multicentric, randomized, controlled, comparative clinical trial to evaluate the safety and efficacy of fixed dose combination of Trypsin 48mg, Bromelain 90mg and Rutoside 100mg tablets in comparison to Trypsin: Chymotrypsin tablets with 1,00,000 armour units of enzymatic activity in wound management.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients aged 18 to 65 years.
- •2. Patients with elective clean and uncontaminated surgery.
- •3. Patients willing to sign informed consent.
排除标准
- •1. Patients with known hypersensitivity to the study drugs.
- •2. Patients with severe renal impairment
- •3. Patients with severe hepatic impairment.
- •4. Patients with hereditary coagulation disorder.
- •5. Women who are pregnant or lactating.
- •6. Patients with any other condition that, in the opinion of the investigator, does not justify his/her
- •inclusion in the study.
研究者
相似试验
招募中
4 期
To evaluate the effectiveness Placentrex Inj along with Azithromycin tablets in patients with Pelvic Inflammatory DiseaseCTRI/2022/09/045480Albert David Limited
Unknown
3 期
A clinical trial to study the effects of two drugs, R-TPR-033 and Erbitux® in patients with head and neck cancer of squamous cell type that has spread to other part of the bodyCTRI/2015/06/005909Reliance Life Sciences Pvt Ltd28
已完成
4 期
Zero Tension Tablet for mild to moderate stress, anxiety and insomnia disorder StudyCTRI/2022/04/042212ALNA BIOTECH PVTLTD100
招募中
4 期
A post marketing surveillance study to evaluate safety and efficacy of fixed dose combination of Ceftriaxone + Sulbactam (Sulbactomax) in patients with various bacterial infectionsCTRI/2012/04/002558Venus Remedies Limited2,500
已完成
4 期
A study of Trypsin, Bromelain, Rutoside and Diclofenac combination in comparison with Diclofenac to observe rapid healing of the wound and reducing pain intensity in surgery patients.CTRI/2021/03/032053Zuventus Healthcare Limited200